ADRA2C and sarcoma: Finally, there was no relationship between ADRA2C expression level and prognosis of BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, esophageal adenocarcinoma (ESAD), GBM, HNSC, KICH, KIRC, LAML, LGG, LIHC, LUAD, LUSC, mesothelioma (MESO), oral squamous cell carcinoma (OSCC), OV, PAAD, PCPG, PRAD, READ, sarcoma (SARC), SKCM, STAD, TGCT, THCA, THYM, UCEC, and UCS.